Philips DirectLife Review: A Tamagotchi for Calorie Counters

Jennifer Vilaga — Mon, 26 Oct 2009 15:39:09 -0400

FTC Sticks to Its Regulations as Blogger Backlash Builds

Jennifer Vilaga — Fri, 16 Oct 2009 16:54:04 -0400

Today, the Federal Trade Commission responded to an "open letter" from online advertisers that asked for the commission's newly updated guidelines to be scrapped because they purportedly "muzzle social media" and, thus, inhibit the freeflow of ideas.

Five Ways Obama Could Best Spend His $1.4M in Nobel Cash

Jennifer Vilaga — Fri, 09 Oct 2009 14:28:53 -0400

Moments after the surprise announcement that Barack Obama had won the Nobel Peace Prize, the Web was atwitter with criticism and speculation about whether he's done anything to deserve it.

Liz Claiborne Downshifts From Macy's to Penney's Brand

Jennifer Vilaga — Thu, 08 Oct 2009 11:15:51 -0400

Liz Claiborne is leaving its longtime partner, Macy's, for an exclusive partnership with J.C. Penney Co., the women's apparel company announced today.

The clothing line, like a lot of other labels in the sector, is struggling. The company cut about 8% of its workforce earlier this year. But to go from Macy's to Penney's? Is this J.C. Penney raising its profile or Liz moving down even deeper into the mass market?

FTC Responds to Blogger Fears: "That $11,000 Fine Is Not True"

Jennifer Vilaga — Wed, 07 Oct 2009 16:08:35 -0400

As you've likely heard by now, the Federal Trade Commission is trying to reign in freebie-grabbing bloggers and graft-happy social media users masquerading as unbiased critics.

Career Advice from Fokko Wientjes, Sustainability Director of DSM

Jennifer Vilaga — Mon, 26 Jan 2009 12:25:54 -0500

1. If someone wanted to land a job at your company today, how would you recommend he or she do it?

HopeLab: Video Games for Health

Jennifer Vilaga — Tue, 25 Nov 2008 20:30:18 -0500

Cancer-afflicted teens often have a hard time sticking to their meds. So Pam Omidyar -- a tech enthusiast with a background in immunology and wife of eBay founder Pierre -- came up with a spoonful of new sugar: video games. Two years ago, HopeLab, Omidyar's not-for-profit, released Re-Mission, a shooter game in which players destroy cancer cells. But it wasn't until this past summer that clinical evidence was published showing that the game actually works.

The Institute for OneWorld Health: Not-for-profit Drugmaking

Jennifer Vilaga — Tue, 25 Nov 2008 20:30:16 -0500

Ten years ago, Victoria Hale wrote a manifesto targeting five diseases in need of drug development and turned it into a business plan for the first pharmaceutical not-for-profit in the United States. Today, her organization, the Institute for OneWorld Health, is on the verge of proving that its no-profit/no-loss model can work. Its first drug, paromomycin -- a treatment for visceral leishmaniasis, an illness spread by sand flies that mostly afflicts the poorest of the poor -- is months from completing its final stage of clinical trials. Up next: malaria.

HopeLab: Video Games for Health

Jennifer Vilaga — Tue, 25 Nov 2008 05:00:25 -0500

The Institute for OneWorld Health: Not-for-profit Drugmaking

Jennifer Vilaga — Tue, 25 Nov 2008 05:00:23 -0500